pinocembrin has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Q; Gao, J; Miao, Y; Wang, H; Wang, Y; Zhang, J; Zhao, W | 1 |
| Cui, Q; Du, G; Wang, H; Wang, Y; Zhao, L | 1 |
2 other study(ies) available for pinocembrin and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Cell Line, Tumor; Flavanones; Humans; Membrane Potential, Mitochondrial; Mitochondria; Neurons; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species | 2014 |
Pinocembrin attenuates MPP(+)-induced neurotoxicity by the induction of heme oxygenase-1 through ERK1/2 pathway.
Topics: 1-Methyl-4-phenylpyridinium; Cell Line, Tumor; Cell Survival; Flavanones; Heme Oxygenase-1; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuroprotective Agents; Signal Transduction; Up-Regulation | 2016 |